| Code | Description | Claims | Beneficiaries | Total Paid |
| 36415 |
Collection of venous blood by venipuncture |
1,227 |
1,045 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
255 |
230 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
96 |
92 |
$5K |
| 87428 |
|
33 |
30 |
$5K |
| 80053 |
Comprehensive metabolic panel |
71 |
65 |
$5K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
35 |
26 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
73 |
66 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
49 |
48 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
25 |
25 |
$2K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14 |
12 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
72 |
68 |
$831.08 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$596.98 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
20 |
18 |
$285.84 |